<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/48-1103.01"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/48-1103.01/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_48_1103_01">
        <akn:num>48-1103.01</akn:num>
        <akn:heading>Needle Exchange Program.</akn:heading>
<akn:subsection eId="subsec_48-1103_01_a">
      <akn:num>(a)</akn:num>
      <akn:content><akn:p>The Mayor is authorized to establish within the Department of Human Services a Needle Exchange Program (“Program”), which may provide clean hypodermic needles and syringes to injecting drug users. Counseling on substance abuse addiction and information on appropriate referrals to drug treatment programs shall be made available to each person to whom a hypodermic needle and syringe is provided. Counseling and information on the Human Immunodeficiency Virus (“HIV”) and appropriate referrals for HIV testing and services shall be made available to each person to whom a hypodermic needle and syringe is provided.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_b">
      <akn:num>(b)</akn:num>
      <akn:content><akn:p>The Program authorized by subsection (a) of this section shall be administered by the Commission on Public Health in the Department of Human Services. Only qualified medical officers, registered nurses, counselors, community based organizations, or other qualified individuals specifically designated by the Commissioner of Public Health shall be authorized to exchange hypodermic needles and syringes under the provisions of subsections (c) through (i) of this section.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_c">
      <akn:num>(c)</akn:num>
      <akn:content><akn:p>The Commissioner of Public Health shall provide all persons participating in the Program authorized by subsection (a) of this section with a written statement of the person’s participation in the Program, signed by the Commissioner of Public Health, or the Commissioner’s designee. No person participating in the Program shall be required to carry such a statement.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_d">
      <akn:num>(d)</akn:num>
      <akn:content><akn:p>Notwithstanding the provisions of § 48-1103 or § 48-904.10, it shall not be unlawful for any person who is participating in the Program authorized by subsection (a) of this section to possess, or for any person authorized by subsection (b) of this section, to deliver any hypodermic syringe or needle distributed as part of the Program.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_e">
      <akn:num>(e)</akn:num>
      <akn:content><akn:p>The District of Columbia, its officers, or employees shall not be liable for any injury or damage resulting from use of, or contact with, any needle exchanged as part of the Program authorized by subsection (a) of this section.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_e_1">
      <akn:num>(e-1)</akn:num>
      <akn:content><akn:p>A community based organization or other qualified individuals designated by the Commissioner of Public Health under subsection (b) of this section shall not be liable for any injury or damage resulting from the use of, or contact with, any needle exchanged as part of the Program authorized by subsection (a) of this section, unless such injury or damage is a direct result of the gross negligence or intentional misconduct of such community based organization or other qualified individuals.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_f">
      <akn:num>(f)</akn:num>
      <akn:content><akn:p>All needles and syringes distributed by the Commission of Public Health as part of the Program shall be made identifiable through the use of permanent markings, or color coding, or any other method determined by the Commissioner to be effective in identifying the needles and syringes.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_g">
      <akn:num>(g)</akn:num>
      <akn:content><akn:p>The Mayor shall issue an annual evaluation report on the Program. The report shall address the following components:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_h">
      <akn:num>(h)</akn:num>
      <akn:content><akn:p>Data on Program participants shall be obtained through interviews. The interviews shall be used to obtain the following information:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-1103_01_i">
      <akn:num>(i)</akn:num>
      <akn:content><akn:p>The Mayor shall explore the feasibility of establishing a system to test used needles and syringes received by the Commission of Public Health for HIV antibody contamination. The Mayor shall prepare a feasibility report on needle and syringe testing and shall submit this report to the Council for review no later than 120 days after June 30, 1992. If the report finds that needles and syringe testing would be beneficial and feasible to implement, such a system shall be incorporated into the Program.</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
